Literature DB >> 10533284

AML1, the target of chromosomal rearrangements in human leukemia, regulates the expression of human complement receptor type 1 (CR1) gene.

J H Kim1, S Lee, J K Rho, S Y Choe.   

Abstract

The human CR1 gene is expressed specifically in hematopoietic cells. It is suggested that some cell-type specific factors which involve in gene-specific activation or repression exist in cells according to the result that the gene expression varies differently depend on differentiation stage. Here, we demonstrate that the integrity of a polyomavirus enhancer core sequence, 5'-TGTGGT-3', is critical to the human CR1 promoter activity. AML1 is a site-specific DNA-binding protein that recognizes the enhancer core motif TGTGGT. We show that the AML1 binds specifically to this site and activates the human CR1 promoter. Furthermore, we demonstrate that the Ets binding site (GGAA) located 2 bp upstream of the AML1 site is also involved in the regulation of the human CR1 promoter activity. Point mutations of either the AML1 or the Ets binding site that abolish the binding of the respective factors result in significant decreases of the human CR1 promoter activity. These results suggest that AML1 and Ets proteins direct the expression of the human CR1 promoter.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10533284     DOI: 10.1016/s1357-2725(99)00048-5

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  4 in total

1.  Fragment of intron 5.2 of the human RUNX1 gene important for transcription activation is neither enhancer nor MAR-element.

Authors:  E N Markova; S V Razin; O L Kantidze
Journal:  Dokl Biochem Biophys       Date:  2012-03-15       Impact factor: 0.788

2.  Erythrocyte complement receptor 1 (CR1) expression level is not associated with polymorphisms in the promoter or 3' untranslated regions of the CR1 gene.

Authors:  I A Cockburn; J A Rowe
Journal:  Int J Immunogenet       Date:  2006-02       Impact factor: 1.466

3.  TSP-1-1223 A/G Polymorphism as a Potential Predictor of the Recurrence Risk of Bladder Cancer in a Chinese Population.

Authors:  Xiao Yang; Pengchao Li; Xuejian Yang; Chao Qin; Qiang Cao; Zhengdong Zhang; Meilin Wang; Hongzhou Cai; Jinbao Gu; Jun Tao; Min Gu; Qiang Lu; Changjun Yin
Journal:  Int J Genomics       Date:  2013-12-03       Impact factor: 2.326

Review 4.  RUNX1: A Regulator of NF-kB Signaling in Pulmonary Diseases.

Authors:  Xiaoju Tang; Ling Sun; Gang Wang; Bojiang Chen; Fengming Luo
Journal:  Curr Protein Pept Sci       Date:  2018       Impact factor: 3.272

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.